The Report Guru

According to the new market research report Defibrillators Market is projected to reach USD 10.88 Billion by 2022 from USD 9.32 Billion in 2017, growing at a CAGR of 3.1%. Factors such as technological advancements in defibrillators, rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training & awareness programs on defibrillators are expected to propel the growth of this market. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=549   As of 2016, some of the prominent players in the defibrillators market were Medtronic (Ireland), St. Jude Medical (US), Boston Scientific (US), Philips (Netherlands), ZOLL Medical (US), BIOTRONIK (Germany), Physio-Control (US), Cardiac Science (US), LivaNova (UK), Nihon Kohden (Japan), SCHILLER (Switzerland), Mindray Medical (China), Mediana (South Korea), METRAX (Germany), and METsis (Turkey). Analysis of the market developments between 2014 and 2017 show that product

According to research report the global vascular imaging market is expected to reach USD 5.95 billion by 2022 from USD 4.35 billion in 2017, at a CAGR of 6.5%. The report covers imaging procedures used to assess blood flow for the effective diagnosis and treatment of various cardiovascular diseases (CVDs). Growing incidence and prevalence of cardiovascular diseases, growing aging population, and technological innovations has led to the wide application of vascular imaging, thus driving the growth of the market. Speak to Analyst : https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=247188200   The vascular imaging market is consolidated in nature due to the presence of large players. The key players in this market are Siemens Healthineers (Germany), GE Healthcare (U.K.), Toshiba Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan), Samsung Medison (South Korea), Shimadzu Corp. (Japan), St. Jude Medical, Inc. (U.S.), TERUMO Corporation (Japan), Konink

According to research report the Elastography Imaging Market is expected to grow from USD 2.5 billion in 2018 to USD 4.6 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 11.0% during the forecast period. The major driving factors in the elastography imaging market are growing incidence of breast cancer and chronic liver diseases, and a rising preference for minimally invasive procedures across the globe. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=107232051 The ultrasound elastography imaging segment is expected to account largest share in the global elastography imaging market during the year 2018. On the basis of modality, the elastography imaging market is segmented into ultrasound and magnetic resonance. Ultrasound imaging involves the imaging of organs by exposing the anatomy to high-frequency sound waves. Elasticity imaging or elastography through ultrasound elastography (USE) provides complementary information to convention

According to research report the report Disposable Medical Device Sensors Market is poised to reach USD 5,936 Million by 2020, growing at a CAGR of 10.3% during the forecast period of 2015 to 2020.This report studies the Disposable Medical Device Sensors market over the forecast period of 2015 to 2020. Disposable medical device sensors are emerging as powerful, cost-effective tools for diagnosing diseases, monitoring vital human parameters, and for various therapeutic applications. Over the years, sensor-based devices have evolved in terms of characteristics, performance, and features due to the continuous improvements in sophistication of electronics in medical and pharmaceutical applications. The advent of IT revolution, wireless sensor technology, disposable sensors, and biosensors in healthcare has played a significant role in the evolution of sensors in healthcare. Moreover, the advent of microsystem technologies such as MEMS, SI-based sensors, and microfluidic chips has revo

According to the new market research report  IVD Quality Control Market is poised to reach USD 1.04 Billion by 2022, at a CAGR of 3.5% from 2017 to 2022. The growth in the IVD quality controls market is mainly driven by the growing number of accredited laboratories and increasing mandates on the use of quality controls from regulatory and accreditation bodies. Similarly, the rise in adoption of third-party controls is also driving the overall growth of the IVD quality controls market. The additional costs involved in the quality control process, budget constraints in hospitals & laboratories, and the unfavorable reimbursement scenario for IVD tests are the major factors restraining the growth of the IVD quality controls market. Speak to Analyst : https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=198032582 In this report, the IVD quality controls market is segmented on the basis of product and service, application, manufacturer type, end user, and region. On the b

According to research report the global cancer biomarkers market is projected to reach USD 20.48 billion by 2022 from USD 11.53 billion in 2017, at a CAGR of 12.2%. Factors such as the rising prevalence of cancer, increasing government support for research in cancer biomarkers, increasing use of biomarkers in the drug discovery and development process, and increasing use of biomarker tests for diagnostic purposes are fueling the growth of this market. However, an unfavorable regulatory and reimbursement scenario and the high capital investments required for biomarker development and validation are some factors expected to restrain the market. In this report, the market is segmented into biomarker type, cancer type, profiling technology, application, and region. The cancer biomarkers market on the basis of cancer type is classified into breast, lung, colorectal, prostate, melanoma, leukemia, thyroid, bladder, non-hodgkin’s lymphoma, kidney, and other cancers including multiple myel

According to the new market research " Pacemakers Market  by Implant ability (External), Technology (Single Chamber, Dual Chamber, CRT-P/Biventricular Pacemaker), Type (Conventional, MRI Compatible), End User (Hospitals and Cardiac Centres, Ambulatory Surgical Center) - Global Forecast to 2023", The pacemakers market is projected to reach USD 4.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 2.0%. Growth in this market is driven by increasing prevalence of cardiovascular diseases and technological advancements in devices. The implantable pacemakers segment, by implant ability, projected to occupy the majority of the market share and grow at the fastest rate during the forecast period. The implantable pacemakers segment is projected to be the fastest-growing segment, by implant ability, during the forecast period. The large share of the implantable pacemakers segment is primarily attributed to the increasing prevalence of CVDs and the rising preference for these

According to the new market research report " Spinal Implants and Surgical Devices Market by Technology (Fusion, Fixation, VCF, Decompression, Motion Preservation), Product (Thoracic, Lumbar, Cervical, Interbody, Kyphoplasty, Artificial Discs, MIS, Biologics, Stimulators) - Global Forecast to 2021" The global spinal implants and surgical devices market is expected to reach USD 17.27 billion by 2021, growing at CAGR of 5.3% during the forecast period. Key factors such continuous advancements in spine surgery technologies, increasing incidence of spinal disorders, technological developments in bone grafting products, increasing demand for minimally invasive surgical procedures, rising geriatric and obese population are driving the growth of this market.                                          Browse 82 market data Tables and 51 Figures spread through 211 Pages and in-depth TOC on "Spinal Implants and Surgical Devices Market by Technology (Fusion, Fixation,

According to the new market research report Nurse Call Systems Market is expected to reach USD 1.75 billion by 2021 from USD 1.12 billion in 2016, at a CAGR of 9.3%. Factors such as the growth in aging population and rising prevalence of chronic diseases, technological advancements and new product launches, increasing healthcare expenditure, and growth in the number of people covered under insurance are the key drivers for the growth of the nurse call systems market. On the other hand, the dearth of trained healthcare IT professionals and stringent regulations for nurse call system installations are the major factors restraining the market growth. The Asian region is projected to register the highest CAGR during the forecast period. Factors such as increasing diabetes prevalence, government initiatives, and growing geriatric population are driving the growth of the Asian market. Speak to Analyst - https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=230909048 Technologi

According to research report the global Lab Accessories Market is expected to reach $504.7 million by 2020 from $327.0 million in 2014, at a CAGR of 7.5% from 2014 to 2020, the global laboratory accessories market is segmented on the basis of products, end users, and regions. Based on products, the market is categorized into microplates, label printers, pipettes, pumps, reagent reservoirs, valves, tubings, and wash stations. The microplates segment includes microplate accessories such as microplate storage racks, well orienters, and well stands. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=90233555 The wash stations and the syringes and syringe pumps segments are expected to account for the largest shares of the market by 2020, accounting for CAGRs of 6.2% and 9.7%, respectively. However, the reagent reservoirs segment is the fastest-growing segment of the laboratory accessories market, with an estimated CAGR of 12.8% during the forecast period

According to the new market research Blood Gas Analyzer Market is expected to reach USD 636.0 Million by 2021, at a CAGR of 4.6% during the forecast period of 2016 to 2021. A number of factors, such as the growing number of patients being treated in ICUs, NICUs, and emergency departments, and the increasing adoption of technologically advanced biosensors and data analysis software for developing next-generation blood gas analyzers are expected to drive the growth of this market in the coming years.   Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=242278963   The rising demand for point-of-care analyzers is another major factor driving the growth of the blood gas analyzer market. Products such as epoc, ABL90, cobas b 123, and GEM 4000 are expected to grow at high CAGRs during the forecast period (2016-2021) owing to advantages such as portability and faster turnaround times offered by them. In the near future, the commercialization of innovative P

According to research report the perfusion systems market is projected to reach USD 1,198.8 million by 2021 from USD 989.4 million in 2016, at a CAGR of 3.9% from 2016 to 2021. The global perfusion systems market is segmented on the basis of type and region. By type, the market is segmented into cardiopulmonary perfusion systems, cell perfusion systems, and ex vivo organ perfusion systems. This market is highly fragmented with different key players for the different types of perfusion systems. The major players in the cardiopulmonary perfusion systems market include Getinge AB (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), Terumo Corporation (Japan), and XENIOS AG (Germany). The major players in the ex vivo organ perfusion systems market are Lifeline Scientific, Inc. (U.S.) and XVIVO Perfusion AB (Sweden), while, Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Harvard Bioscience, Inc. (U.S.), and ALA Scientific Instruments, Inc. (U

According to research report the single-use bioreactors market is expected to reach USD 2,685.1 Million by 2022 from USD 997.6 Million in 2017, at a CAGR 21.9%. The major players operating in the single-use bioreactors market include Sartorius Stedim Biotech (France), Merck Millipore (Germany), GE Healthcare (US), Danaher (US), and, Thermo Fisher Scientific (US). Increasing adoption of SUBs among small companies and startups and reduced automation complexity are the major factors driving the adoption of single-use bioreactors. Most companies focus on launching new products to compete in the market. The players also focus on increasing their presence in high-growth markets through agreements, expansions, and acquisitions. Sartorius Stedim Biotech (France), Merck Millipore (Germany), GE Healthcare (US), Danaher (US), and Thermo Fisher Scientific (US) focus on product launches and enhancements to strengthen their position in the market. Speak to Analyst: https://www.marketsandmarke

According to the new market research report Sternal Closure Systems Market is projected to reach USD 2.61 Billion by 2023 from USD 2.02 Billion in 2018, at a CAGR of 5.2% during the forecast period. Factors such as technological advancements in sternotomy techniques, increasing target patient population coupled with the subsequent increase in the number of surgical procedures, and growing availability of medical reimbursements across major markets are expected to drive the demand for sternal closure systems during the study period. Based on product, the closure devices segment is expected to register the highest growth rate during the forecast period Based on product, the sternal closure systems market is divided into closure devices and bone cement. Among these segments, closure devices are expected to grow at the highest CAGR during the forecast period. Factors such as increasing number of complex cardiovascular surgeries and growing availability of medical reimbursements across